Solving the antidepressant efficacy question: effect sizes in major depressive disorder

Area of Science:

• Psychiatry and Behavioral Sciences
• Clinical Psychology
• Pharmacology

Background:

• Conflicting conclusions exist regarding antidepressant efficacy in major depressive disorder (MDD).
• Previous reviews and meta-analyses have yielded divergent results on antidepressant effectiveness for acute and maintenance treatment.
• This study addresses the ongoing debate on antidepressant utility in MDD.

Purpose of the Study:

• To critically evaluate recent major depressive disorder (MDD) studies on antidepressants.
• To reanalyze US Food and Drug Administration (FDA) database studies previously examined by Kirsch et al.
• To assess the efficacy of antidepressants in acute and maintenance phases of MDD.

Main Methods:

• Effect estimates from MDD studies were compiled.
• A reanalysis of acute depression studies involved correcting for statistical floor effects to calculate relative effect size differences.
• A meta-analysis of maintenance treatment literature was critiqued.

Main Results:

• Antidepressant benefits were observed in moderate and severe depression, but not in mild depression.
• A linear increase in relative antidepressant versus placebo benefit was noted, from 5% in mild to 16% in severe depression.
• The analysis indicated issues with previous interpretations of maintenance treatment studies, particularly concerning placebo efficacy and bias.

Conclusions:

• Antidepressants are effective for moderate to severe acute depressive episodes.
• Efficacy is not demonstrated in mild depression, even after correcting for statistical floor effects.
• The long-term efficacy of antidepressants for maintenance treatment is unproven, but they are not indicated as harmful.